- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00060112 | Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma | terminated | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00079352 | Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00087217 | 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00089271 | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00003970 | Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00030693 | Vaccine Therapy in Treating Patients With Metastatic Solid Tumors | terminated | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00042809 | Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00049088 | Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00062127 | Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00077155 | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00078962 | GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00086970 | Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors | terminated | Phase 1 | 32 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00098891 | MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005973 | BMS-214662 in Treating Patients With Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00024206 | SU6668 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00028561 | BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors | terminated | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00084786 | Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00003282 | EF5 in Treating Patients With Solid Tumors | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00028587 | PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 96 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00028821 | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00101244 | SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00017238 | KRN5500 in Treating Patients With Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2013 | clinicaltrials |
| NCT00026169 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure | completed | Phase 1 | 69 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00086983 | Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors | terminated | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00891072 | Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00047034 | E7389 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00089089 | Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas | terminated | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00118170 | Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function | completed | Phase 1 | 150 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00124605 | Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00849550 | Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.(COBRA) | completed | Phase 1 | 32 | Herbert HurwitzOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00098969 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants(IRB 2004-535) | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Dec 17, 2012 | clinicaltrials |
| NCT00349167 | PR-104 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | Proacta, IncorporatedINDUSTRY | 1 | Nov 30, 2012 | clinicaltrials |
| NCT00551005 | Etoposide and Celecoxib in Patients With Advanced Cancer | completed | Phase 1 | 58 | City of Hope Medical CenterOTHER | 0 | Nov 22, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00551889 | Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer | completed | Phase 1 | 57 | City of Hope Medical CenterOTHER | 0 | Nov 12, 2012 | clinicaltrials |
| NCT00003132 | Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00004002 | PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00005990 | R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00003021 | Bizelesin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00093730 | BMS-599626 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 9 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | completed | Phase 1 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00004886 | MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00098943 | NGR-TNF in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00482521 | CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment | completed | Phase 1 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00003708 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 32 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003709 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003710 | Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003712 | CCI-779 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 15 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jan 25, 2013source: clinicaltrials